Eleven patients carried variants in genes commonly associated with CFCS, as follows, BRAF (seven patients), MAP2K1 (one patient), MAP2K2 (two patients), and KRAS (one patient). Here, MAP2K1 is linked to cardiofaciocutaneous syndrome 1.